The swine flu vaccine is a potential challenger to narcolepsy?

World Health Organization (WHO) recommended on Tuesday a more thorough investigation of the possible impact Pandemrix vaccine manufacturers GlaxoSmithKline and other vaccines against H1N1 influenza on the occurrence of narcolepsy, a rare sleep disorder. WHO has published recommendations on the basis of the Finnish research has shown that children are immunized Pandemrix had nine times more likely to narkolepsy, sudden and unexpected fall in a dream.

WHO spokeswoman Alison Brunier said in Geneva that the WHO will not change the existing recommendations on Pandemrix, because they "needed a more thorough investigation of the relationship between narcolepsy and vaccination not only Pandemrixhas other vaccines against H1N1 . " GSK, the manufacturer Pandemrix, said that studies the Finnish study but it was too early for conclusions.

In addition to GSK's H1N1 pandemic vaccine is produced Novartis, Sanofi, Aventis, CSL and Baxter. Increased risk of narcolepsy has been studied only in the case Pandemrix, no need to investigate the impact of other vaccines, "said Brunier. According to data from GSK's more than 31 million doses Pandemrix distributed in 47 countries. GSK has been notified of 162 cases of narcolepsy to 31 January 2011., of which 70 per cent in Finland and Sweden.
Kindly Bookmark and Share it:

No comments:

Post a Comment

Designed By An Insurance | Proudly Powered by Blogger